The effect of tetrathiomolybdate on cytokine expression, angiogenesis, and tumor growth in squamous cell carcinoma of the head and neck

Archives of Otolaryngology - Head and Neck Surgery

Volumn 131, Issue 3, 2005, Pages 204-211

  Teknos, Theodoros N ^a,d   Islam, Mozaffarul ^a   Arenberg, Douglas A ^a   Pan, Quintin ^a   Carskadon, Shannon L ^a   Abarbanell, Aaron M ^a   Marcus, Benjamin ^a   Paul, Supriti ^a   Vandenberg, Curtis D ^a   Carron, Michael ^a   Nor, Jacques E ^b,c   Merajver, Sofia D ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; INTERLEUKIN 6; INTERLEUKIN 8; TETRATHIOMOLYBDIC ACID; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; MICROTUBULE ASSEMBLY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RAT; SCID MOUSE; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH; TUMOR VASCULARIZATION; VASCULAR RING;

ANGIOGENESIS INHIBITORS; ANIMALS; BIOPSY, NEEDLE; CARCINOMA, SQUAMOUS CELL; CELL MOVEMENT; CYTOKINES; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, SCID; MOLYBDENUM; NEOVASCULARIZATION, PATHOLOGIC; PROBABILITY; RATS; RATS, SPRAGUE-DAWLEY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SPECIES SPECIFICITY; TUMOR BURDEN; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 20044395251     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.131.3.204     Document Type: Article

References (33)

1. Mann E, Spiro J, Chen L, Kreutzer D. Cytokine expression by head and neck squamous cell carcinoma. Am J Surg. 1992;164:567-573.
2. Cohen R, Contrino J, Spiro J, Mann E, Chen L, Kreutzer D. Interleukin-8 expression by head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 1995;121:202-209.
3. Woodworth C, McMullin E, Iglesias M, Plowman G. Interleukin 1α and tumor necrosis factor α stimulate autocrine amphiregulin expression and proliferation of human papillomavirus-immortalized and carcinoma-derived cervical epithelial cells. Proc Natl Acad Sci U S A. 1995;92:2840-2844.
4. Smith D, Polverini P, Kunkel S, et al. Inhibition of interleukin 8 attenuates angiogenesis in bronchogeniccarcinoma. J Exp Med. 1994;179:1409-1415.
5. Chen Z, Colon I, Ortiz N, et al. Effects of interleukin-1α, interleukin-1 receptor antagonist, and neutralizing antibody on proinflammatory cytokine expression by human squamous cell carcinoma lines. Cancer Res. 1998;58:3668-3676.
6. Chen Z, Malhotra PS, Thomas GR, et al. Expression of proinflammatory and proangiogenic cytokines in human head and neck cancer patients. Clin Cancer Res. 1999;5:1369-1379.
7. Van Waes C, Chen Z, Callister M, et al. Cytokines in the immune pathogenesis and therapy of head and neck cancer. In: Veldman JE, Passali D, Lim DJ, eds. Immuno- and Molecular Biology in ORL - State of Art. The Hague, the Netherlands: Kubler Publications. In press.
8. Ondrey FG, Dong G, Sun Woo J, et al. Constitutive activation of transcription factor NFκB, AP-1, and NF-IL6 in human head and neck squamous cell carcinoma cell lines that express proinflammatory and proangiogenic cytokines. Mol Carcinog. 1999;26:119-129.
9. Young MR, Wright MA, Lozano Y, et al. Increased recurrence and metastasis in patients whose primary head and neck squamous cell carcinomas secreted granulocyte macrophage colony stimulating factor and contains CD34 plus natural suppressor cells. Int J Cancer. 1997;74:69-74.
10. Beg AA, Baltimore D. An essential role for NFκB in preventing TNFα induced cell death. Science. 1996;274:782-784.
11. Duffey DC, Chen Z, Dong G, et al. Expression of dominant negative mutant inhibitor-κB of nuclear factor κB in human head and neck squamous cell carcinoma inhibits survival proinflammatory cytokine expression in vivo. Cancer Res. 1999;59:3468-3474.
12. Sunwoo JB, Chen Z, Dong G, et al. Novel Proteosome inhibitor PS-341 inhibits activation of nuclear factor κB, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma. Clin Cancer Res. 2001;7:1419-1428.
13. Cox C, Teknos TN, Barrios M, Brewer GJ, Dick RD, Merajver SD. The role of copper suppression as an antiangiogeneic strategy in head and neck squamous cell carcinoma. Laryngoscope. 2001;111:696-701.
14. Pan Q, Kleer CG, Van Golen KL, et al. Copper deficiency induce by tetrathiomolybdate suppresses tumor growth and angiogenesis. Cancer Res. 2002;62:4854-4859.
15. Landriscina M, Bagala C, Mandanova A, et al. Copper induces the assembly of a multiprotein aggregate implicated in the release of fibroblast growth factor 1 in response to stress. J Biol Chem. 2001;276:25549-25557.
16. Krause C, Carey TE, Ott R, Hurbis C, McClatchey K, Regezi J. Human squamous cell carcinoma establishment in characterization of new permanent cell lines. Arch Otolaryngol. 1981;107:703-710.
17. White ES, Strom SRB, Wys NL, Arenberg DA. Non small cell lung cancer cells induce monocytes to increase expression of angiogenetic activity. J Immunol. 2001;166:7549-7555.
18. Nor JE, Peters MC, Christensen JB, et al. Engineering and characterization of functional human vessels in immunodeficient mice. Lab Invest. 2001;81:453-463.
19. Mandinov L, Mandinova A, Kyurkchiev S, et al. Copper chelation represses the vascular response to injury. Proc Natl Acad Sci U S A. 2003;100:6700-6705.
20. Brewer GJ, Dick RD, Yuzbasiyan-Gurkin V, Tankanow R, Young AB, Kluin KG. Initial therapy of patients with Wilson's disease with tetrathiomolybdate. Arch Neurol. 1991;48:42-47.
21. Hu GF. Copper stimulates proliferation of human endothelial cells under culture. J Cell Biochem. 1998;69:326-335.
22. McAuslan BR, Reilly W. Endothelial cell phagokinesis in response to specific metal ions. Exp Cell Res. 1980;130:147-157.
23. Brewer GJ, Dick RD, Grover DK, et al. Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent; phase I study. Clin Cancer Res. 2000;6:1-10.
24. Redman BG, Esper P, Pan Q, et al. Phase II trial of tetrathiomolybdate in patients with advanced kidney cancer. Clin Cancer Res. 2003;9:1666-1672.
25. Mandinova A, Soldi R, Granziani I, et al. S100A13 mediates the copper-dependent stress-induced release of IL-1α from both human U937 and murine NIH 3T3 cells. J Cell Sci. 2003;116:2687-2696.
26. Landriscina M, Bagala C, Mandinova A, et al. Copper induces the assembly of a multiprotein aggregate implicated in the release of fibroblast growth factor 1 in response to stress. J Biol Chem. 2001;276:25549-25557.
27. Hemker HC, Van Rijn JL, Rosing J, Van Dieijen G, Bevers EM, Zwaal RF. Platelet membrane involvement in blood coagulation. Blood Cells. 1983;9:303-317.
28. Galang CK, Garcia-Ramirez J, Solski PA, et al. Oncogenetic Neu/ErbB-2 increases ets, AP-1, and NF-κB-dependent gene expression, and inhibiting ets activation blocks Neu-mediated cellular transformation. J Biol Chem. 1996;271:7992-7998.
29. Teknos TN, Cox C, Chepeha DB, Bradford CR, Fisher S, Wolf GT. Tumor angiogenesis as a predictive marker for organ preservation in patients with advanced laryngeal carcinoma. Laryngoscope. 2002;112:844-851.
30. Teknos TN, Cox C, Yoo S, et al. Elevated serum vascular endothelial growth factor and decreased survival in advanced laryngeal carcinoma. Head Neck. 2002;24:1004-1011.
31. Wang CY, Cusack JC Jr, Liu R, Baldwin AS Jr. Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB. Nat Med. 1999;5:412-417.
32. Wang CY, Mayo MW, Baldwin AS Jr. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science. 1996;274:784-787.
33. Cox C, Merajver SD, Yoo S, et al. Inhibition of the growth of squamous cell carcinoma by tetrathiomolybdate-induced copper suppression in a murine model. Arch Otolaryngol Head Neck Surg. 2003;129:781-785.